Revolutionising cellular therapies for cancer and beyond

We’re developing more precise and more accessible treatment options for patients with solid cancers, endometriosis and Alzheimer’s disease

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.

Learn more about us

Some of our partners

Latest news

Going Virtual at Cartherics

By Christine Filippis / April 27, 2020
COVID-19 may well be responsible for shutting down much of the country, but the Cartherics crew carries on in electronically...
Read More

Good news from Cartherics

By Christine Filippis / March 25, 2020
Doctoral student Anisha Balachandran has submitted her thesis with compliments all-round By Leigh Dayton Image from Left to right :...
Read More

Cartherics and the Coronavirus

By Christine Filippis / March 24, 2020
A message from Cartherics CEO Alan Trounson 'Due to the escalation of public health measures to prevent the spread of...
Read More